[Federal Register: September 11, 2008 (Volume 73, Number 177)]
[Notices]
[Page 52861-52862]
[DOCID:fr11se08-72]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2006-N-0178] (formerly Docket No. 2006N-0362)

Draft Guidance for Industry and Food and Drug Administration
Staff; Class II Special Controls Guidance Document: Absorbable
Hemostatic Device; Availability; Reopening of Comment Period

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; reopening of comment period.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is reopening until
October 14, 2008, the comment period for a draft guidance entitled
``Class II Special Controls Guidance Document: Absorbable Hemostatic
Device.'' The draft guidance describes a means by which the absorbable
hemostatic device may comply with the requirements of special controls
if it is reclassified. FDA is reopening the comment period to update
comments and to receive any new information. Elsewhere in this issue of
the Federal Register, FDA is reopening the comment period on a proposed
rule to reclassify the absorbable hemostatic device from class III
(premarket approval) into class II (special controls).

DATES Although you can comment on any guidance at any time (see 21 CFR
10.115(g)(5)), to ensure that the agency considers your comments on
this draft guidance before it begins work on the final version of the
guidance, submit written or electronic comments on the draft guidance
October 14, 2008.

ADDRESS: Submit written comments to the Division of Dockets Management
(HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061,
Rockville, MD 20852. Submit electronic comments to http://
www.regulations.gov. See the SUPPLEMENTARY INFORMATION section for
electronic access to the draft guidance document.

FOR FURTHER INFORMATION CONTACT: David Krause, Center for Devices and
Radiological Health (HFZ-410), Food and Drug Administration, 9200
Corporate Blvd., Rockville, MD 20850,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

I. Background

    In the Federal Register of October 31, 2006 (71 FR 63728), FDA
published a proposed rule to reclassify the absorbable hemostatic
device intended to produce hemostasis from class III (premarket) into
class II (special controls). In the same issue of the Federal Register
(71 FR 63774), FDA published a notice of availability of a draft
guidance document entitled ``Class II Special Controls Guidance
Document: Absorbable Hemostatic Device.'' FDA invited interested
persons to comment on the draft guidance document by January 29, 2007.
In the Federal Register of May 8, 2007 (72 FR 26134), FDA published a
notice reopening the comment period for 30 days.
    On July 2, 2007, FDA received a petition under 21 CFR 10.30 and
10.35 requesting that the agency refrain from issuing a final
regulation for the proposed reclassification and the draft special
controls guidance for the absorbable hemostatic device until an updated
and complete administrative record is made available to the public. The
petitioner also requested that FDA reopen the rulemaking for the
proposed reclassification to allow submission of comments based on the
administrative record. Elsewhere in this issue of the Federal Register,
FDA is reopening the comment period on the proposed rule for 30 days.
Because the issues presented by the guidance document are intertwined
with those presented by the proposed rule, FDA is reopening the comment
period on the guidance document for the same period.

II. Electronic Access

    Persons interested in obtaining a copy of the draft guidance may do
so by using the Internet. To receive the draft guidance document
entitled ``Class II Specials Controls Document: Absorbable Hemostatic
Device,'' you may either send an e-mail request to<EMAIL_ADDRESS>to receive an electronic copy of the document, or send a fax request to
240-276-3151 to receive a hard copy. Please use the document number
1558 to identify the guidance you are requesting.
    CDRH maintains an entry on the Internet for easy access to
information including text, graphics, and files that may be downloaded
to a personal computer with Internet access. Updated on a regular
basis, the CDRH home page includes device safety alerts, Federal
Register reprints, information on premarket submissions (including
lists of approved applications and manufacturers'' addresses), small
manufacturer'' assistance, information on video conferencing and
electronic submissions, Mammography Matters, and other device-oriented
information. The CDRH Web site may be accessed at http://www.fda.gov/
cdrh. A search capability for all CDRH guidance documents is available
at http://www.fda.gov/cdrh/guidance.html. Guidance documents are also
available at http://www.regulations.gov.

III. Request for Comments

    Interested persons may submit to the Division of Dockets Management
(see ADDRESSES) written or electronic comments on the draft guidance
document. Submit a single copy of electronic comments or two paper
copies of any mailed comments, except that individuals may submit one
paper copy. Comments are to be identified with the docket number found
in brackets in the heading of this document. Received comments may be
seen in the Division of Dockets Management between 9 a.m. and 4 p.m.
Monday through Friday.
    Please note that on January 15, 2008, the FDA Division of Dockets
Management Web site transitioned to the Federal Dockets Management
System (FDMS). FDMS is a Government-wide, electronic docket management
system. Electronic comments submissions will be accepted by FDA through
FDMS only.

    Dated: September 4, 2008.
Jeffrey Shuren,
Associate Commissioner for Policy and Planning.
[FR Doc. E8-21197 Filed 9-10-08; 8:45 am]

BILLING CODE 4160-01-S


[Federal Register Volume 88, Number 191 (Wednesday, October 4, 2023)]
[Notices]
[Page 68602]
[FR Doc No: 2023-21906]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings

    Take notice that the Commission has received the following Natural
Gas and Oil Pipeline Rate and Refund Report filings:

Filings Instituting Proceedings

    Docket Numbers: RP23-1066-000.
    Applicants: Enable Mississippi River Transmission, LLC.
    Description: 4(d) Rate Filing: Housekeeping Filing to be effective
10/26/2023.
    Filed Date: 9/26/23.
    Accession Number: 20230926-5107.
    Comment Date: 5 p.m. ET 10/10/23..

    Docket Numbers: RP23-1067-000.
    Applicants: Enable Mississippi River Transmission, LLC.
    Description: 4(d) Rate Filing: Housekeeping Filing to be effective
10/26/2023.
    Filed Date: 9/26/23.
    Accession Number: 20230926-5108.
    Comment Date: 5 p.m. ET 10/10/23.

    Docket Numbers: RP23-1068-000.
    Applicants: Iroquois Gas Transmission System, L.P.
    Description: 4(d) Rate Filing: 9.27.23 Negotiated Rates--Sequent
Energy Management LLC .R-3075-17 to be effective 11/1/2023.
    Filed Date: 9/27/23.
    Accession Number: 20230927-5014.
    Comment Date: 5 p.m. ET 10/10/23.

    Docket Numbers: RP23-1069-000.
    Applicants: Iroquois Gas Transmission System, L.P.
    Description: 4(d) Rate Filing: 9.27.23 Negotiated Rates--Sequent
Energy Management LLC R-3075-18 to be effective 11/1/2023.
    Filed Date: 9/27/23.
    Accession Number: 20230927-5016.
    Comment Date: 5 p.m. ET 10/10/23.

    Docket Numbers: RP23-1070-000.
    Applicants: Iroquois Gas Transmission System, L.P.
    Description: 4(d) Rate Filing: 9.27.23 Negotiated Rates--Shell
Energy North America (US), L.P. R-2170-25 to be effective 11/1/2023.
    Filed Date: 9/27/23.
    Accession Number: 20230927-5017.
    Comment Date: 5 p.m. ET 10/10/23.

    Docket Numbers: RP23-1071-000.
    Applicants: Iroquois Gas Transmission System, L.P.
    Description: 4(d) Rate Filing: 9.27.23 Negotiated Rates--Shell
Energy North America (US), L.P. R-2170-26 to be effective 11/1/2023.
    Filed Date: 9/27/23.
    Accession Number: 20230927-5023.
    Comment Date: 5 p.m. ET 10/10/23.

    Any person desiring to intervene, to protest, or to answer a
complaint in any of the above proceedings must file in accordance with
Rules 211, 214, or 206 of the Commission's Regulations (18 CFR 385.211,
385.214, or 385.206) on or before 5:00 p.m. Eastern time on the
specified comment date. Protests may be considered, but intervention is
necessary to become a party to the proceeding.

Filings in Existing Proceedings

    Docket Numbers: RP23-991-001.
    Applicants: Viking Gas Transmission Company.
    Description: Tariff Amendment: Amendment to EPCRA and Request for
Action by November 1, 2023 to be effective 11/1/2023.
    Filed Date: 9/26/23.
    Accession Number: 20230926-5089.
    Comment Date: 5 p.m. ET 10/10/23.

    Any person desiring to protest in any the above proceedings must
file in accordance with Rule 211 of the Commission's Regulations (18
CFR 385.211) on or before 5:00 p.m. Eastern time on the specified
comment date.
    The filings are accessible in the Commission's eLibrary system
(https://elibrary.ferc.gov/idmws/search/fercgensearch.asp) by querying
the docket number.
    eFiling is encouraged. More detailed information relating to filing
requirements, interventions, protests, service, and qualifying
facilities filings can be found at: http://www.ferc.gov/docs-filing/efiling/filing-req.pdf. For other information, call<PHONE_NUMBER>
(toll free). For TTY, call<PHONE_NUMBER>.
    The Commission's Office of Public Participation (OPP) supports
meaningful public engagement and participation in Commission
proceedings. OPP can help members of the public, including landowners,
environmental justice communities, Tribal members and others, access
publicly available information and navigate Commission processes. For
public inquiries and assistance with making filings such as
interventions, comments, or requests for rehearing, the public is
encouraged to contact OPP at<PHONE_NUMBER> or [email protected].

    Dated: September 27, 2023.
Debbie-Anne A. Reese,
Deputy Secretary.
[FR Doc. 2023-21906 Filed 10-3-23; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register: June 3, 2008 (Volume 73, Number 107)]
[Notices]
[Page 31696-31697]
[DOCID:fr03jn08-48]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2008-N-0314]

Agency Information Collection Activities; Proposed Collection;
Comment Request; Recall Regulations

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing an
opportunity for public comment on the proposed collection of certain
information by the agency. Under the Paperwork Reduction Act of 1995
(the PRA), Federal agencies are required to publish notice in the
Federal Register concerning each proposed collection of information,
including each proposed extension of an existing collection of
information, and to allow 60 days for public comment in response to the
notice. This notice solicits comments on FDA's recall regulations and
provides guidance to manufacturers on recall responsibilities.

DATES: Submit written or electronic comments on the collection of
information by August 4, 2008.

ADDRESSES: Submit electronic comments on the collection of information
to http://www.regulations.gov. Submit written comments on the
collection of information to the Division of Dockets Management (HFA-
305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061,
Rockville, MD 20852. All comments should be identified with the docket
number found in brackets in the heading of this document.

FOR FURTHER INFORMATION CONTACT: Elizabeth Berbakos, Office of the
Chief Information Officer (HFA-250), Food and Drug Administration, 5600
Fishers Lane, Rockville, MD 20857,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3520), Federal
agencies must obtain approval from the Office of Management and Budget
(OMB) for each collection of information they conduct or sponsor.
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A))
requires Federal agencies to provide a 60-day notice in the Federal
Register concerning each proposed collection of information, including
each proposed extension of an existing collection of information,
before submitting the collection to OMB for approval. To comply with
this requirement, FDA is publishing notice of the proposed collection
of information set forth in this document.
    With respect to the following collection of information, FDA
invites comments on these topics: (1) Whether the proposed collection
of information is necessary for the proper performance of FDA's
functions, including whether the information will have practical
utility; (2) the accuracy of FDA's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used; (3) ways to enhance the quality,
utility, and clarity of the information to be collected; and (4) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques, when
appropriate, and other forms of information technology.

FDA Recall Regulations--21 CFR Part 7 (OMB Control Number 0910-0249)--
Extension

    Section 701 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C.
371) and 21 CFR part 7, subpart C, set forth the recall regulations
(guidelines) and provides guidance to manufacturers on recall
responsibilities. The guidelines apply to all FDA regulated products
(i.e., food, including animal feed; drugs, including animal drugs;
medical devices, including in vitro diagnostic products; cosmetics; and
biological products intended for human use). These responsibilities
include development of a recall strategy that requires time by the firm
to determine the actions or procedures required to manage the recall
(21 CFR 7.42); providing FDA with complete details of the recall
including reason(s) for the removal or correction, risk evaluation,
quantity produced, distribution information, firm's recall strategy, a
copy of any recall communication(s), and a contact official (21 CFR
7.46); notifying direct accounts of the recall, providing guidance
regarding further distribution, giving instructions as to what to do
with the product, providing recipients with a ready means of reporting
to the recalling firm (21 CFR 7.49); submitting periodic status reports
so that FDA may assess the progress of the recall. Status report
information may be determined by, among other things evaluation return
reply cards, effectiveness checks and product returns (21 CFR 7.53);
and providing the opportunity for a firm to request in writing that FDA
terminate the recall (21 CFR 7.55).
    A search of the FDA database was performed to determine the number
of recalls that took place during fiscal year 2007. The resulting
number of recalls from this database search (2,166) is used in
estimating the current annual reporting burden for this report. FDA
estimates the total annual industry burden to collect and provide the
previous information to 216,600 burden hours.
    The following table is a summary of the estimated annual burden
hours for recalling firms (manufacturers, processors, and distributors)
to comply with the voluntary reporting requirements of FDA's recall
regulations.
    Recognizing that there may be a vast difference in the information
collection and reporting time involved in different recalls of FDA's
regulated products, FDA estimates on average the burden of collection
for recall information to be as follows:

                                 Table 1.--Estimated Annual Reporting Burden\1\
----------------------------------------------------------------------------------------------------------------
                         No. of        Annual Frequency     Total Annual        Hours Per
  21 CFR Section      Respondents       per  Response        Responses           Response         Total Hours
----------------------------------------------------------------------------------------------------------------
Recall Strategy                2,166                  1              2,166                 20             43,320
 7.42
----------------------------------------------------------------------------------------------------------------
Firm Initiated                 2,166                  1              2,166                 30             64,980
 Recall and
 Recall
 Communications
 7.46 and 7.49
----------------------------------------------------------------------------------------------------------------

Recall Status                  2,166                  4              8,664                 10             86,640
 Reports and
 Follow-up 7.53
----------------------------------------------------------------------------------------------------------------
Termination of a               2,166                  1              2,166                 10             21,660
 Recall 7.55(b)
----------------------------------------------------------------------------------------------------------------
Total                                                                                216,600
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
  information.

    The annual reporting burdens are explained as follows:

I. Reporting

A. Recall Strategy

    Request firms develop a recall strategy including provision for
public warnings and effectiveness checks. Under this portion of the
collection of information, the agency estimates it will receive 2,166
responses annually.

B. Firm Initiated Recall and Recall Communications

    Request firms voluntarily remove or correct foods and drugs (human
or animal), cosmetics, medical devices, and biologicals to immediately
notify the appropriate FDA district office of such actions. The firm is
to provide complete details of the recall reason, risk evaluation,
quantity produced, distribution information, firms' recall strategy and
a contact official as well as requires firms to notify their direct
accounts of the recall and to provide recipients with a ready means of
reporting to the recalling firm. Under these portions of the collection
of information, the agency estimates it will receive 2,166 responses
annually for each.

C. Recall Status Reports

    Request that recalling firms provide periodic status reports so the
FDA can ascertain the progress of the recall. This collection of
information will generate approximately 8,664 responses annually.

D. Termination of a Recall

    Provide the firms an opportunity to request in writing that FDA end
the recall. The agency estimates it will receive 2,166 responses
annually.
    Please note that on January 15, 2008, the FDA Division of Dockets
Management Web site transitioned to the Federal Dockets Management
System (FDMS). FDMS is a Government-wide, electronic docket management
system. Electronic comments or submissions will be accepted by FDA only
through FDMS at http://www.regulations.gov.

    Dated: May 27, 2008.
Jeffrey Shuren,
Associate Commissioner for Policy and Planning.
[FR Doc. E8-12339 Filed 6-2-08; 8:45 am]

BILLING CODE 4160-01-S


[Federal Register Volume 88, Number 32 (Thursday, February 16, 2023)]
[Rules and Regulations]
[Pages 10020-10022]
[FR Doc No: 2023-03176]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Part 39

[Docket No. FAA-2022-1408; Project Identifier MCAI-2022-00857-T;
Amendment 39-22325; AD 2023-02-18]
RIN 2120-AA64

Airworthiness Directives; Airbus SAS Airplanes

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: The FAA is superseding Airworthiness Directive (AD) 2022-09-
03, which applied to certain Airbus SAS Model A350-941 and -1041
airplanes. AD 2022-09-03 required revising the existing maintenance or
inspection program, as applicable, to incorporate new or more
restrictive airworthiness limitations. This AD was prompted by a
determination that new or more restrictive airworthiness limitations
are necessary. This AD continues to require the actions in AD 2022-09-
03 and requires revising the existing maintenance or inspection
program, as applicable, to incorporate additional new or more
restrictive airworthiness limitations, as specified in a European Union
Aviation Safety Agency (EASA) AD, which is incorporated by reference
(IBR). The FAA is issuing this AD to address the unsafe condition on
these products.

DATES: This AD is effective March 23, 2023.
    The Director of the Federal Register approved the incorporation by
reference of a certain publication listed in this AD as of March 23,
2023.
    The Director of the Federal Register approved the incorporation by
reference of a certain other publication listed in this AD as of June
16, 2022 (87 FR 29030, May 12, 2022).

ADDRESSES:
    AD Docket: You may examine the AD docket at regulations.gov under
Docket No. FAA-2022-1408; or in person at Docket Operations between 9
a.m. and 5 p.m., Monday through Friday, except Federal holidays. The AD
docket contains this final rule, the mandatory continuing airworthiness
information (MCAI), any comments received, and other information. The
address for Docket Operations is U.S. Department of Transportation,
Docket Operations, M-30, West Building Ground Floor, Room W12-140, 1200
New Jersey Avenue SE, Washington, DC 20590.
    Material Incorporated by Reference:
     For material identified in this final rule, contact EASA,
Konrad-Adenauer-Ufer 3, 50668 Cologne, Germany; telephone +49 221 8999
000; email [email protected]; website easa.europa.eu. You may find
this material on the EASA website at ad.easa.europa.eu.
     You may view this material at the FAA, Airworthiness
Products Section, Operational Safety Branch, 2200 South 216th St., Des
Moines, WA. For information on the availability of this material at the
FAA, call<PHONE_NUMBER>. It is also available at regulations.gov under
Docket No. FAA-2022-1408.

FOR FURTHER INFORMATION CONTACT: Dat Le, Aerospace Engineer, Large
Aircraft Section, FAA, International Validation Branch, 2200 South
216th St., Des Moines, WA 98198; telephone<PHONE_NUMBER>; email
[email protected].

SUPPLEMENTARY INFORMATION:

Background

    The FAA issued a notice of proposed rulemaking (NPRM) to amend 14
CFR part 39 to supersede AD 2022-09-03, Amendment 39-22023 (87 FR
29030, May 12, 2022) (AD 2022-09-03). AD 2022-09-03 applied to certain
Airbus SAS Model A350-941 and -1041 airplanes. AD 2022-09-03 required
revising the existing maintenance or inspection program, as applicable,
to incorporate new or more restrictive airworthiness limitations. The
FAA issued AD 2022-09-03 to address the potential failure of certain
life-limited parts, which could result in reduced structural integrity
of the airplane.
    The NPRM published in the Federal Register on November 9, 2022 (87
FR 67575). The NPRM was prompted by AD 2022-0124, dated June 28, 2022,
issued by EASA, which is the Technical Agent for the Member States of
the European Union (EASA AD 2022-0124) (referred to after this as the
MCAI). EASA AD 2022-0124 superseded EASA AD 2021-0206 (which
corresponds to FAA AD 2022-09-03). The MCAI states that new or more
restrictive airworthiness limitations have been developed.
    In the NPRM, the FAA proposed to continue to require the actions in
AD 2022-09-03. The NPRM also proposed to require revising the existing
maintenance or inspection program, as applicable, to incorporate
additional new or more restrictive airworthiness limitations, as
specified in EASA AD 2022-0124. The FAA is issuing this AD to address
the potential failure of certain life-limited parts, which could result
in reduced structural integrity of the airplane.
    You may examine the MCAI in the AD docket at regulations.gov under
Docket No. FAA-2022-1408.

Discussion of Final Airworthiness Directive

Comments

    The FAA received a comment from the Air Line Pilots Association,
International (ALPA), who supported the NPRM without change.

Conclusion

    This product has been approved by the aviation authority of another
country and is approved for operation in the United States. Pursuant to
the FAA's bilateral agreement with this State of Design Authority, it
has notified the FAA of the unsafe condition described in the MCAI
referenced above. The FAA reviewed the relevant data, considered the
comment received, and determined that air safety requires adopting this
AD as proposed. Accordingly, the FAA is issuing this AD to address the
unsafe condition on this product. Except for minor editorial changes,
this AD is

adopted as proposed in the NPRM. None of the changes will increase the
economic burden on any operator.

Related Service Information Under 1 CFR Part 51

    The FAA reviewed EASA AD 2022-0124, which specifies new or more
restrictive airworthiness limitations for airplane structures and safe
life limits.
    This AD also requires EASA AD 2021-0206, dated September 15, 2021,
which the Director of the Federal Register approved for incorporation
by reference as of June 16, 2022 (87 FR 29030, May 12, 2022).
    This material is reasonably available because the interested
parties have access to it through their normal course of business or by
the means identified in ADDRESSES.

Costs of Compliance

    The FAA estimates that this AD affects 30 airplanes of U.S.
registry. The FAA estimates the following costs to comply with this AD:
    The FAA estimates the total cost per operator for the retained
actions from AD 2022-09-03 to be $7,650 (90 work-hours x $85 per work-
hour).
    The FAA has determined that revising the existing maintenance or
inspection program takes an average of 90 work-hours per operator,
although the agency recognizes that this number may vary from operator
to operator. Since operators incorporate maintenance or inspection
program changes for their affected fleet(s), the FAA has determined
that a per-operator estimate is more accurate than a per-airplane
estimate.
    The FAA estimates the total cost per operator for the new actions
to be $7,650 (90 work-hours x $85 per work-hour).

Authority for This Rulemaking

    Title 49 of the United States Code specifies the FAA's authority to
issue rules on aviation safety. Subtitle I, section 106, describes the
authority of the FAA Administrator. Subtitle VII: Aviation Programs,
describes in more detail the scope of the Agency's authority.
    The FAA is issuing this rulemaking under the authority described in
Subtitle VII, Part A, Subpart III, Section 44701: General requirements.
Under that section, Congress charges the FAA with promoting safe flight
of civil aircraft in air commerce by prescribing regulations for
practices, methods, and procedures the Administrator finds necessary
for safety in air commerce. This regulation is within the scope of that
authority because it addresses an unsafe condition that is likely to
exist or develop on products identified in this rulemaking action.

Regulatory Findings

    The FAA has determined that this AD will not have federalism
implications under Executive Order 13132. This AD will not have a
substantial direct effect on the States, on the relationship between
the national government and the States, or on the distribution of power
and responsibilities among the various levels of government.
    For the reasons discussed above, I certify that this AD:
    (1) Is not a ``significant regulatory action'' under Executive
Order 12866,
    (2) Will not affect intrastate aviation in Alaska, and
    (3) Will not have a significant economic impact, positive or
negative, on a substantial number of small entities under the criteria
of the Regulatory Flexibility Act.

List of Subjects in 14 CFR Part 39

    Air transportation, Aircraft, Aviation safety, Incorporation by
reference, Safety.

The Amendment

    Accordingly, under the authority delegated to me by the
Administrator, the FAA amends 14 CFR part 39 as follows:

PART 39--AIRWORTHINESS DIRECTIVES

0
1. The authority citation for part 39 continues to read as follows:

    Authority:  49 U.S.C. 106(g), 40113, 44701.

Sec.  39.13  [Amended]

0
2. The FAA amends Sec.  39.13 by:
0
a. Removing Airworthiness Directive 2022-09-03, Amendment 39-22023 (87
FR 29030, May 12, 2022); and
0
b. Adding the following new airworthiness directive:

2023-02-18 Airbus SAS: Amendment 39-22325; Docket No. FAA-2022-1408;
Project Identifier MCAI-2022-00857-T.

(a) Effective Date

    This airworthiness directive (AD) is effective March 23, 2023.

(b) Affected ADs

    This AD replaces AD 2022-09-03, Amendment 39-22023 (87 FR 29030,
May 12, 2022) (AD 2022-09-03).

(c) Applicability

    This AD applies to Airbus SAS Model A350-941 and -1041
airplanes, certificated in any category, with an original
airworthiness certificate or original export certificate of
airworthiness issued on or before May 2, 2022.

(d) Subject

    Air Transport Association (ATA) of America Code 05, Time Limits/
Maintenance Checks.

(e) Unsafe Condition

    This AD was prompted by a determination that new or more
restrictive airworthiness limitations are necessary. The FAA is
issuing this AD to address the potential failure of certain life-
limited parts, which could result in reduced structural integrity of
the airplane.

(f) Compliance

    Comply with this AD within the compliance times specified,
unless already done.

(g) Retained Revision of the Existing Maintenance or Inspection
Program, With No Changes

    This paragraph restates the requirements of paragraph (j) of AD
2022-09-03, with no changes. For airplanes with an original
airworthiness certificate or original export certificate of
airworthiness issued on or before June 30, 2021: Except as specified
in paragraph (h) of this AD, comply with all required actions and
compliance times specified in, and in accordance with, European
Union Aviation Safety Agency (EASA) AD 2021-0206, dated September
15, 2021 (EASA AD 2021-0206). Accomplishing the revision of the
existing maintenance or inspection program required by paragraph (j)
of this AD terminates the requirements of this paragraph.

(h) Retained Exceptions to EASA AD 2021-0206, With No Changes

    This paragraph restates the requirements of paragraph (k) of AD
2022-09-03, with no changes.
    (1) Where EASA AD 2021-0206 refers to its effective date, this
AD requires using June 16, 2022 (the effective date of AD 2022-09-
03).
    (2) The requirement specified in paragraph (1) of EASA AD 2021-
0206 does not apply to this AD.
    (3) Paragraph (2) of EASA AD 2021-0206 specifies revising ``the
approved AMP'' within 12 months after its effective date, but this
AD requires revising the existing maintenance or inspection program,
as applicable, within 90 days after June 16, 2022 (the effective
date of AD 2022-09-03).
    (4) The initial compliance time for doing the tasks specified in
paragraph (2) of EASA AD 2021-0206 is at the applicable
``limitations'' as incorporated by the requirements of paragraph (2)
of EASA AD 2021-0206, or within 90 days after June 16, 2022 (the
effective date of AD 2022-09-03), whichever occurs later.
    (5) The provisions specified in paragraphs (3) and (4) of EASA
AD 2021-0206 do not apply to this AD.
    (6) The ``Remarks'' section of EASA AD 2021-0206 does not apply
to this AD.

(i) Retained Restrictions on Alternative Actions and Intervals, With a
New Exception

    This paragraph restates the requirements of paragraph (l) of AD
2022-09-03, with a new exception. Except as required by paragraph

(j) of this AD, after the revision of the existing maintenance or
inspection program has been accomplished as required by paragraph
(g) of this AD, no alternative actions (e.g., inspections) and
intervals are allowed unless they are approved as specified in the
provisions of the ``Ref. Publications'' section of EASA AD 2021-
0206.

(j) New Revision of the Existing Maintenance or Inspection Program

    Except as specified in paragraph (k) of this AD: Comply with all
required actions and compliance times specified in, and in
accordance with, EASA AD 2022-0124, dated June 28, 2022 (EASA AD
2022-0124). Accomplishing the revision of the existing maintenance
or inspection program required by this paragraph terminates the
requirements of paragraph (g) of this AD.

(k) Exceptions to EASA AD 2022-0124

    (1) The requirement specified in paragraph (1) of EASA AD 2022-
0124 does not apply to this AD.
    (2) Paragraph (2) of EASA AD 2022-0124 specifies revising ``the
approved AMP'' within 12 months after its effective date, but this
AD requires revising the existing maintenance or inspection program,
as applicable, within 90 days after the effective date of this AD.
    (3) The initial compliance time for complying with the
limitations specified in paragraph (2) of EASA AD 2022-0124 is at
the applicable ``limitations'' as incorporated by the requirements
of paragraph (2) of EASA AD 2022-0124, or within 90 days after the
effective date of this AD, whichever occurs later.
    (4) The provisions specified in paragraphs (3) and (4) of EASA
AD 2022-0124 do not apply to this AD.
    (5) This AD does not adopt the ``Remarks'' section of EASA AD
2022-0124.

(l) New Provisions for Alternative Actions and Intervals

    After the existing maintenance or inspection program has been
revised as required by paragraph (j) of this AD, no alternative
actions (e.g., inspections) and intervals are allowed unless they
are approved as specified in the provisions of the ``Ref.
Publications'' section of EASA AD 2022-0124.

(m) Additional AD Provisions

    The following provisions also apply to this AD:
    (1) Alternative Methods of Compliance (AMOCs): The Manager,
International Validation Branch, FAA, has the authority to approve
AMOCs for this AD, if requested using the procedures found in 14 CFR
39.19. In accordance with 14 CFR 39.19, send your request to your
principal inspector or responsible Flight Standards Office, as
appropriate. If sending information directly to the International
Validation Branch, send it to the attention of the person identified
in paragraph (n) of this AD. Information may be emailed to: [email protected]. Before using any approved AMOC, notify your
appropriate principal inspector, or lacking a principal inspector,
the manager of the responsible Flight Standards Office.
    (2) Contacting the Manufacturer: For any requirement in this AD
to obtain instructions from a manufacturer, the instructions must be
accomplished using a method approved by the Manager, International
Validation Branch, FAA; or EASA; or Airbus SAS's EASA Design
Organization Approval (DOA). If approved by the DOA, the approval
must include the DOA-authorized signature.

(n) Additional Information

    For more information about this AD, contact Dat Le, Aerospace
Engineer, Large Aircraft Section, FAA, International Validation
Branch, 2200 South 216th St., Des Moines, WA 98198; telephone 516-
228-7317; email [email protected].

(o) Material Incorporated by Reference

    (1) The Director of the Federal Register approved the
incorporation by reference (IBR) of the service information listed
in this paragraph under 5 U.S.C. 552(a) and 1 CFR part 51.
    (2) You must use this service information as applicable to do
the actions required by this AD, unless the AD specifies otherwise.
    (3) The following service information was approved for IBR on
March 23, 2023.
    (i) European Union Aviation Safety Agency (EASA) AD 2022-0124,
dated June 28, 2022.
    (ii) [Reserved]
    (4) The following service information was approved for IBR on
June 16, 2022 (87 FR 29030, May 12, 2022).
    (i) European Union Aviation Safety Agency (EASA) AD 2021-0206,
dated September 15, 2021.
    (ii) [Reserved]
    (5) For EASA ADs 2021-0206 and 2022-0124, contact EASA, Konrad-
Adenauer-Ufer 3, 50668 Cologne, Germany; telephone +49 221 8999 000;
email [email protected]; website easa.europa.eu. You may find these
EASA ADs on the EASA website at ad.easa.europa.eu.
    (6) You may view this service information at the FAA,
Airworthiness Products Section, Operational Safety Branch, 2200
South 216th St., Des Moines, WA. For information on the availability
of this material at the FAA, call<PHONE_NUMBER>.
    (7) You may view this service information that is incorporated
by reference at the National Archives and Records Administration
(NARA). For information on the availability of this material at
NARA, email [email protected], or go to: www.archives.gov/federal-register/cfr/ibr-locations.html.

    Issued on January 30, 2023.
Christina Underwood,
Acting Director, Compliance & Airworthiness Division, Aircraft
Certification Service.
[FR Doc. 2023-03176 Filed 2-15-23; 8:45 am]
BILLING CODE 4910-13-P


ECOLOGICAL MID-CYCLE SUBCOMMITTEE

DRAFT AGENDA

April 26, 2007

12:00 pm – 2:00 pm Eastern Time

Participation by Teleconference Only

866-299-3188

code:<PHONE_NUMBER>#

12:00-12:10pm	Welcome	Dr. Jim Clark,

	-  Roll Call	Subcommittee Chair

	- Overview of Agenda

12:10-12:15 pm	Administrative Procedures	Heather Drumm

		Subcommittee DFO

12:15-12:30 pm	Material Overview	Dr. Rick Linthurst

Office of Research and Development

12:30-12:45 pm	Overview of Charge/	Dr. Jim Clark

	Rating Program Performance	Subcommittee Chair &

		Phillip Juengst

Office of Research and Development

12:45-1:05 pm	Overall Progress Review	Dr. Kevin Summers

Office of Research and Development

1:05-1:25 pm	Goal 1 Progress	Dr. Mike McDonald

		Office of Research and

		Development

1:25-1:30 pm	Public Comment

1:30-2:00 pm 	Preparation for Next Call and Face-to-Face 	Dr. Jim Clark,

	Meeting	Subcommittee Chair

	- Discuss Writing Assignments

	- Identify Additional Information Needs

2:00 pm	Adjourn

            A Federal Advisory Committee for the U.S. Environmental Protection Agency’s Office of Research and Development